By American Society of Clinical Oncology | June 3, 2019ASCO 2019: Adding Enzalutamide to Standard First-Line Treatment Improves Survival for Men With Metastatic Hormone-Sensitive Prostate Cancer
By American Society of Clinical Oncology | June 3, 2019ASCO 2019: Use of Broader Criteria for Clinical Trial Enrollment Would Double Number of Eligible Patients With Lung Cancer
By American Society of Clinical Oncology | June 6, 2018Maintenance Chemotherapy Extends Life for Children With a Rare Cancer
By American Society of Clinical Oncology | May 17, 2018New Regimens Improve Survival for Children and Young Adults With T-Cell Cancers
By American Society of Clinical Oncology | May 17, 2018Shorter Trastuzumab Treatment for HER2+ Breast Cancer can be as Effective, With Fewer Cardiac Side-Effects